Compare TMCI & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMCI | VERI |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 142.2M |
| IPO Year | 2021 | 2017 |
| Metric | TMCI | VERI |
|---|---|---|
| Price | $3.91 | $1.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.77 | ★ $7.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.8M |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $212,690,000.00 | $92,637,000.00 |
| Revenue This Year | N/A | $52.20 |
| Revenue Next Year | $8.18 | $3.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.59 | N/A |
| 52 Week Low | $1.17 | $1.27 |
| 52 Week High | $7.78 | $9.42 |
| Indicator | TMCI | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 33.23 |
| Support Level | $2.46 | N/A |
| Resistance Level | $4.47 | $2.35 |
| Average True Range (ATR) | 0.45 | 0.10 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 16.67 | 19.77 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.